{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:14:42Z","timestamp":1792574082208,"version":"4.5.0"},"reference-count":309,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632025PY02"],"award-info":[{"award-number":["2632025PY02"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20240096"],"award-info":[{"award-number":["BK20240096"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M783610"],"award-info":[{"award-number":["2025M783610"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T180968"],"award-info":[{"award-number":["2025T180968"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LKLY25H180014"],"award-info":[{"award-number":["LKLY25H180014"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018541","name":"Science Fund for Distinguished Young Scholars of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018576","name":"Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372113"],"award-info":[{"award-number":["82372113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114946","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:00:34Z","timestamp":1776985234000},"page":"114946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Precision nose-to-brain therapeutics: Advances in drug delivery systems and emerging preclinical models"],"prefix":"10.1016","volume":"395","author":[{"given":"Yinglan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengle","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114946_bb0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/bmj.p749","article-title":"FDA approves over the counter sale of naloxone to reverse drug overdoses","volume":"380","author":"Tanne","year":"2023","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/epi.18195","article-title":"Benzodiazepine rescue medication administration for seizure clusters: real-world retrospective outcomes","volume":"66","author":"Chiang","year":"2025","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/pharmaceutics16070929","article-title":"Nasal drug delivery and nose-to-brain delivery technology development status and trend analysis: based on questionnaire survey and patent analysis","volume":"16","author":"Ge","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114946_bb0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jconrel.2023.12.054","article-title":"Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases","volume":"366","author":"Huang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114946_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","article-title":"Synaptic dysfunction in Alzheimer\u2019s disease: mechanisms and therapeutic strategies","volume":"195","author":"Chen","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.114946_bb0045","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1917030","article-title":"Acute ischemic stroke","volume":"383","author":"Powers","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114946_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102178","article-title":"In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model","volume":"48","author":"Kelmanson","year":"2021","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb0060","first-page":"460","article-title":"Tissue acidosis associated with ischemic stroke to guide neuroprotective drug delivery","volume":"9","author":"O","year":"2020","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.jconrel.2026.114946_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drudis.2020.10.017","article-title":"Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap","volume":"26","author":"Starokozhko","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.114946_bb0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/ACM.0b013e3181ccd618","article-title":"Defining translational research: implications for training","volume":"85","author":"Rubio","year":"2010","journal-title":"Acad. Med."},{"key":"10.1016\/j.jconrel.2026.114946_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175824","article-title":"FDA modernization act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb0080","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1021\/acs.molpharmaceut.5c00386","article-title":"Intranasal therapeutics for neurodegenerative disorders: overcoming the blood-brain barrier with smart formulations and devices","volume":"22","author":"Kumar","year":"2025","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0085","first-page":"105","article-title":"Estimation of nasal cavity and conchae volumes by stereological method","volume":"71","author":"Emirzeoglu","year":"2012","journal-title":"Folia Morphol. (Warsz)"},{"key":"10.1016\/j.jconrel.2026.114946_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2023","journal-title":"J. Pharm. Investig."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0095","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","article-title":"Physiology and pathophysiology of human airway mucus","volume":"102","author":"Hill","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cis.2017.12.005","article-title":"Gel-forming mucin interactome drives mucus viscoelasticity","volume":"252","author":"Demouveaux","year":"2018","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028241","article-title":"Cilia and mucociliary clearance","volume":"9","author":"Bustamante-Marin","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0110","first-page":"L647","article-title":"Structure, function, and regulation of cellular tight junctions","volume":"262","author":"Schneeberger","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2026.114946_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115196","article-title":"Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway","volume":"207","author":"Chen","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114946_bb0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.114946_bb0125","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.2174\/1381612827666210820100723","article-title":"A recent update on intranasal delivery of high molecular weight proteins, peptides, and hormones","volume":"27","author":"Sharma","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2026.114946_bb0130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/js960503w","article-title":"Diffusion of drugs in native and purified gastrointestinal mucus","volume":"86","author":"Larhed","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/pharmaceutics14030588","article-title":"Strategies to improve drug strength in nasal preparations for brain delivery of low aqueous solubility drugs","volume":"14","author":"Pires","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.114946_bb0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(97)00065-3","article-title":"Prodrugs for nasal drug delivery","volume":"29","author":"Krishnamoorthy","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400304","article-title":"Intranasal delivery of curcumin nanoparticles improves neuroinflammation and neurological deficits in mice with intracerebral hemorrhage","volume":"8","author":"Duan","year":"2024","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2026.114946_bb0150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.tim.2021.03.014","article-title":"Respiratory mucus as a virus-host range determinant","volume":"29","author":"Wallace","year":"2021","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jconrel.2022.11.051","article-title":"Mucus adhesion vs. mucus penetration? Screening nanomaterials for nasal inhalation by MD simulation","volume":"353","author":"Gao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2017.12.002","article-title":"Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery","volume":"124","author":"Newby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb0165","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/acs.biomac.6b00164","article-title":"Size-limited penetration of nanoparticles into porcine respiratory mucus after aerosol deposition","volume":"17","author":"Murgia","year":"2016","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","article-title":"Mucus as a barrier to lipophilic drugs","volume":"453","author":"Sigurdsson","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114946_bb0175","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.bpj.2010.01.012","article-title":"Characterization of particle translocation through mucin hydrogels","volume":"98","author":"Lieleg","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2026.114946_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113604","article-title":"A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer\u2019s disease combination therapy","volume":"381","author":"Chen","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.addr.2017.09.020","article-title":"Chemical modification of drug molecules as strategy to reduce interactions with mucus","volume":"124","author":"Ara\u00fajo","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb0190","article-title":"Muco-penetrating lipid nanoparticles having a liquid core for enhanced intranasal mRNA delivery","volume":"12","author":"Maniyamgama","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.114946_bb0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.addr.2017.10.001","article-title":"Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties","volume":"124","author":"Wu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb0200","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1021\/acs.nanolett.3c02128","article-title":"PH-mediated mucus penetration of Zwitterionic Polydopamine-modified silica nanoparticles","volume":"23","author":"Ma","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114946_bb0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","article-title":"Beyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials","volume":"124","author":"Khutoryanskiy","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114946_bb0210","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jps.10537","article-title":"Stability of PEGylated salmon calcitonin in nasal mucosa","volume":"93","author":"Na","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1021\/acs.molpharmaceut.0c01074","article-title":"Uptake and transport of ultrafine nanoparticles (quantum dots) in the nasal mucosa","volume":"18","author":"Bejgum","year":"2021","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0230","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","article-title":"Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree","volume":"111","author":"Prego","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0235","doi-asserted-by":"crossref","first-page":"31878","DOI":"10.1039\/D2RA05750F","article-title":"Bioevaluation of magnetic mesoporous silica rods: cytotoxicity, cell uptake and biodistribution in zebrafish and rodents","volume":"12","author":"Grzelak","year":"2022","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0240","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1038\/s41467-018-05061-3","article-title":"Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114946_bb0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114946_bb0250","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1007\/s12274-022-4601-2","article-title":"Rod-like mesoporous silica nanoparticles facilitate oral drug delivery via enhanced permeation and retention effect in mucus","volume":"15","author":"Liu","year":"2022","journal-title":"Nano Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0255","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1021\/acsnano.1c01146","article-title":"Janus nanoparticles: from fabrication to (Bio)applications","volume":"15","author":"Zhang","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0260","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acs.molpharmaceut.3c00773","article-title":"Tadpole-like anisotropic polymer\/lipid Janus nanoparticles for nose-to-brain drug delivery: importance of geometry, elasticity on mucus-penetration ability","volume":"21","author":"Okmen Altas","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114946_bb0265","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1021\/acs.jpcc.2c00461","article-title":"Rationalizing the effect of shape and size in nanoparticle-based glues","volume":"126","author":"Xie","year":"2022","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2026.114946_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122881","article-title":"Supramolecular cyclodextrin-based reservoir as nasal delivery vehicle for rivastigmine to brain","volume":"348","author":"Wang","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.114946_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116922","article-title":"Self-healing hyaluronic acid hydrogels based on dynamic Schiff base linkages as biomaterials","volume":"250","author":"Li","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.114946_bb0280","article-title":"Nano-crosslinked dynamic hydrogels for biomedical applications","volume":"20","author":"Wang","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"14","key":"10.1016\/j.jconrel.2026.114946_bb0285","article-title":"Enhanced delivery of neuroactive drugs via nasal delivery with a self-healing supramolecular gel","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.114946_bb0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0295","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jconrel.2020.12.050","article-title":"In situ-gelling starch nanoparticle (SNP)\/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide","volume":"330","author":"Majcher","year":"2021","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.jconrel.2026.114946_bb0300","doi-asserted-by":"crossref","first-page":"R938","DOI":"10.1016\/j.cub.2021.06.093","article-title":"Mucus","volume":"31","author":"McShane","year":"2021","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.002","article-title":"Neuroprotective peptides fused to arginine-rich cell penetrating peptides: neuroprotective mechanism likely mediated by peptide endocytic properties","volume":"153","author":"Meloni","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.114946_bb0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2014.06.022","article-title":"In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin","volume":"189","author":"Nielsen","year":"2014","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114946_bb0315","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/acs.accounts.3c00769","article-title":"Lipid-based nanoparticle functionalization with coiled-coil peptides for in vitro and in vivo drug delivery","volume":"57","author":"Aschmann","year":"2024","journal-title":"Acc. Chem. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114946_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500821","article-title":"Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides","volume":"1","author":"Pang","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114946_bb0325","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jconrel.2023.03.002","article-title":"Protamine-mediated efficient transcellular and transmucosal delivery of proteins","volume":"356","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0330","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jconrel.2021.06.007","article-title":"Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2","volume":"335","author":"Akita","year":"2021","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0335","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/pharmaceutics15030973","article-title":"A novel preparation technique for human nasal respiratory mucosa to disclose its glycosylation pattern for bioadhesive drug delivery","volume":"15","author":"Gausterer","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.114946_bb0340","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijpharm.2011.04.026","article-title":"Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG\u2013PLA nanoparticles in Calu-3 cells","volume":"413","author":"Shen","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0345","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejpb.2011.10.012","article-title":"A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-\u03b225\u201335-treated rats following intranasal administration","volume":"80","author":"Wu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0165-6147(02)01989-2","article-title":"The role of the transferrin-transferrin-receptor system in drug delivery and targeting","volume":"23","author":"Li","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0355","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.apsb.2025.02.035","article-title":"Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for Alzheimer\u2019s disease therapy","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0360","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.peptides.2008.10.005","article-title":"Differential expression of LHRH-receptor in bovine nasal tissue and its role in deslorelin delivery","volume":"30","author":"Sundaram","year":"2009","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb0365","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1096\/fj.09-129825","article-title":"Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium","volume":"23","author":"Sundaram","year":"2009","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb0370","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","article-title":"Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-\u03b3 and IL-4","volume":"130","author":"Soyka","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb0375","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/all.16064","article-title":"Updated epithelial barrier dysfunction in chronic rhinosinusitis: targeting pathophysiology and treatment response of tight junctions","volume":"79","author":"Huang","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2026.114946_bb0380","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.addr.2005.01.009","article-title":"Occludin: structure, function and regulation","volume":"57","author":"Feldman","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb0385","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7150\/ijbs.45885","article-title":"Tight junctions and their regulation by non-coding RNAs","volume":"17","author":"Zhao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2018.09.008","article-title":"The claudins: from tight junctions to biological systems","volume":"44","author":"Tsukita","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0395","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.cell.2019.10.011","article-title":"Phase separation of zonula occludens proteins drives formation of tight junctions","volume":"179","author":"Beutel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114946_bb0400","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217561120","article-title":"Cholesterol-rich domain formation mediated by ZO proteins is essential for tight junction formation","volume":"120","author":"Shigetomi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0405","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/pharmaceutics16060746","article-title":"Chitosan nanoparticles for intranasal drug delivery","volume":"16","author":"Omidian","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114946_bb0410","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0015-0282(03)01868-5","article-title":"Intranasal administration (IN) of leuprolide to healthy women","volume":"80","author":"Muse","year":"2003","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0415","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4161\/hv.27449","article-title":"Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines","volume":"10","author":"Smith","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.114946_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155848","article-title":"Advances and perspectives on pharmacological activities and mechanisms of the monoterpene borneol","volume":"132","author":"Hu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2026.114946_bb0425","doi-asserted-by":"crossref","first-page":"23684","DOI":"10.1021\/acsnano.4c08279","article-title":"Tailored Borneol-modified lipid nanoparticles nasal spray for enhanced nose-to-brain delivery to central nervous system diseases","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114946_bb0430","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jconrel.2024.09.035","article-title":"Mechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon","volume":"375","author":"Dong","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113834","article-title":"Intracerebral delivery of the ionic liquid form of edaravone via nose-to-brain delivery route for treating cerebral ischemia\/reperfusion injury","volume":"383","author":"Fukuta","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106290","article-title":"Application of ionic liquid to enhance the nose-to-brain delivery of etodolac","volume":"178","author":"Tanigawa","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0445","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41598-017-18561-x","article-title":"Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0450","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13346-012-0089-8","article-title":"CriticalSorb\u2122: enabling systemic delivery of macromolecules via the nasal route","volume":"3","author":"Lewis","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0455","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2012.06.014","article-title":"CriticalSorb\u2122: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15","volume":"162","author":"Illum","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0460","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/10717544.2020.1825542","article-title":"Increased antitumor efficacy of ginsenoside Rh(2) via mixed micelles: in vivo and in vitro evaluation","volume":"27","author":"Xia","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114946_bb0465","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.addr.2021.02.008","article-title":"Target specific tight junction modulators","volume":"171","author":"Brunner","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb0470","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1128\/MCB.01811-05","article-title":"Normal establishment of epithelial tight junctions in mice and cultured cells lacking expression of ZO-3, a tight-junction MAGUK protein","volume":"26","author":"Adachi","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104994","article-title":"ZO-1 knockout by TALEN-mediated gene targeting in MDCK cells: involvement of ZO-1 in the regulation of cytoskeleton and cell shape","volume":"9","author":"Tokuda","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0480","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s42003-022-03794-y","article-title":"MRI tractography reveals the human olfactory nerve map connecting the olfactory epithelium and olfactory bulb","volume":"5","author":"Kurihara","year":"2022","journal-title":"Commun. Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0485","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0490","article-title":"Nanoodor particles deliver drugs to central nervous system via olfactory pathway","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0495","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jemt.1070230105","article-title":"Morphology of olfactory epithelium in humans and other vertebrates","volume":"23","author":"Morrison","year":"1992","journal-title":"Microsc. Res. Tech."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0500","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41467-025-57278-8","article-title":"Serum-tolerant polymeric complex for stem-cell transfection and neural differentiation","volume":"16","author":"Jin","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114946_bb0505","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1016\/j.apsb.2022.04.001","article-title":"New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: combining with intranasal delivery","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114946_bb0510","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1248\/bpb.b23-00135","article-title":"Development of functional chimeric nanoparticles by membrane fusion of small extracellular vesicles and drug-encapsulated liposomes","volume":"46","author":"Fukuta","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2026.114946_bb0515","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.stemcr.2016.07.024","article-title":"Intranasal oncolytic virotherapy with CXCR4-enhanced stem cells extends survival in mouse model of glioma","volume":"7","author":"Dey","year":"2016","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0520","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, Physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114946_bb0525","article-title":"TAT modification facilitates nose-to-brain transport of intact mPEG-PDLLA micelles: evidence from aggregation-caused quenching probes","volume":"19","author":"Ahmad","year":"2020","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.jconrel.2026.114946_bb0530","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb0535","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/acs.nanolett.2c05056","article-title":"Intranasal pathway for nanoparticles to enter the central nervous system","volume":"23","author":"Kou","year":"2023","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jamp.2022.0005","article-title":"Delivery of dihydroergotamine mesylate to the upper nasal space for the acute treatment of migraine: technology in action","volume":"35","author":"Cooper","year":"2022","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114946_bb0545","doi-asserted-by":"crossref","first-page":"31732","DOI":"10.1038\/srep31732","article-title":"Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0550","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3390\/pharmaceutics15061720","article-title":"The upper nasal space: option for systemic drug delivery, mucosal vaccines and \u201cnose-to-brain\u201d","volume":"15","author":"Shrewsbury","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0555","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2025.01.017","article-title":"Engineered commensals for targeted nose-to-brain drug delivery","volume":"188","author":"Shen","year":"2025","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114946_bb0560","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/pharmaceutics11100540","article-title":"Liposomal formulations for nose-to-brain delivery: recent advances and future perspectives","volume":"11","author":"Hong","year":"2019","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0565","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","article-title":"Intranasal drug delivery: An efficient and non-invasive route for systemic administration: focus on opioids","volume":"134","author":"Grassin-Delyle","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"6512","key":"10.1016\/j.jconrel.2026.114946_bb0570","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abb8739","article-title":"Glymphatic failure as a final common pathway to dementia","volume":"370","author":"Nedergaard","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0575","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00031.2020","article-title":"Fluid transport in the brain","volume":"102","author":"Rasmussen","year":"2022","journal-title":"Physiol. Rev."},{"issue":"7996","key":"10.1016\/j.jconrel.2026.114946_bb0580","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41586-023-06899-4","article-title":"Nasopharyngeal lymphatic plexus is a hub for cerebrospinal fluid drainage","volume":"625","author":"Yoon","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114946_bb0585","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41573-022-00500-9","article-title":"The glymphatic system: implications for drugs for central nervous system diseases","volume":"21","author":"Lohela","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114946_bb0590","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.semcancer.2021.05.005","article-title":"Metabolic regulation on the immune environment of glioma through gut microbiota","volume":"86","author":"Lyu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0595","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","article-title":"Extracellular protein components of amyloid plaques and their roles in alzheimer\u2019s disease pathology","volume":"16","author":"Rahman","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0600","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0605","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114946_bb0610","article-title":"Aducanumab: European agency rejects Alzheimer's drug over efficacy and safety concerns","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb0615","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1073\/pnas.0813404106","article-title":"Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice","volume":"106","author":"Thakker","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb0620","first-page":"4491","article-title":"Mimosine functionalized gold nanoparticles (Mimo-AuNPs) suppress \u03b2-amyloid aggregation and neuronal toxicity","volume":"6","author":"Anand","year":"2021","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0625","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, aducanumab, and Gantenerumab-binding profiles to different forms of Amyloid-Beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0630","doi-asserted-by":"crossref","first-page":"10868","DOI":"10.1038\/s41598-024-61691-2","article-title":"Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities","volume":"14","author":"S\u00f6derberg","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb0635","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.1799","article-title":"Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils","volume":"17","author":"Ahmed","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0640","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jcis.2022.01.051","article-title":"KLVFF oligopeptide-decorated amphiphilic cyclodextrin nanomagnets for selective amyloid beta recognition and fishing","volume":"613","author":"Mazzaglia","year":"2022","journal-title":"J. Colloid Interface Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0645","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cclet.2020.09.009","article-title":"Detection of amyloid-beta by Fmoc-KLVFF self-assembled fluorescent nanoparticles for Alzheimer\u2019s disease diagnosis","volume":"32","author":"Liu","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.114946_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.153210","article-title":"Intranasal liposomes co-delivery of a\u03b2-targeted KLVFF and ROS-responsive ceria for synergistic therapy of Alzheimer\u2019s disease","volume":"494","author":"Shan","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"30","key":"10.1016\/j.jconrel.2026.114946_bb0655","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203182","article-title":"Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer\u2019s disease therapy","volume":"18","author":"Yang","year":"2022","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0660","article-title":"Modulating the aggregation of amyloid proteins by macrocycles","volume":"3","author":"Li","year":"2022","journal-title":"Aggregate"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0665","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41557-018-0164-y","article-title":"Heteromultivalent peptide recognition by co-assembly of cyclodextrin and calixarene amphiphiles enables inhibition of amyloid fibrillation","volume":"11","author":"Xu","year":"2019","journal-title":"Nat. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0670","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006483","article-title":"Recognition and removal of amyloid-\u03b2 by a Heteromultivalent macrocyclic coassembly: a potential strategy for the treatment of Alzheimer\u2019s disease","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"issue":"34","key":"10.1016\/j.jconrel.2026.114946_bb0675","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1021\/bi700455c","article-title":"Surface structure of amyloid-beta fibrils contributes to cytotoxicity","volume":"46","author":"Yoshiike","year":"2007","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114946_bb0680","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.31635\/ccschem.020.202000561","article-title":"Coassembly of macrocyclic Amphiphiles for anti-\u03b2-amyloid therapy of Alzheimer\u2019s disease","volume":"3","author":"Pan","year":"2021","journal-title":"CCS Chem."},{"issue":"48","key":"10.1016\/j.jconrel.2026.114946_bb0685","doi-asserted-by":"crossref","first-page":"33032","DOI":"10.1021\/acsnano.4c05693","article-title":"Multi targeted therapy for Alzheimer\u2019s disease by guanidinium-modified calixarene and cyclodextrin co-assembly loaded with insulin","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb0690","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/alz.13789","article-title":"Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer\u2019s disease","volume":"20","author":"Huang","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0695","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","article-title":"Low-density lipoprotein receptor-related protein 1: a physiological a\u03b2 homeostatic mechanism with multiple therapeutic opportunities","volume":"136","author":"Sagare","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0700","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","article-title":"Microglia contribute to the propagation of a\u03b2 into unaffected brain tissue","volume":"25","author":"d\u2019Errico","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0705","doi-asserted-by":"crossref","first-page":"29779","DOI":"10.1021\/acsnano.4c09449","article-title":"Intranasal Carrier-free nanomodulator addresses both symptomatology and etiology of Alzheimer\u2019s disease by restoring neuron plasticity and reprogramming lesion microenvironment","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114946_bb0710","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41591-022-01926-9","article-title":"Anti-inflammatory clearance of amyloid-\u03b2 by a chimeric gas6 fusion protein","volume":"28","author":"Jung","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb0715","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/acsnano.5b07522","article-title":"High-density lipoproteins: nature\u2019s multifunctional nanoparticles","volume":"10","author":"Kuai","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114946_bb0720","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304213120","article-title":"Nasal delivery of polymeric nanoDisc mobilizes a synergy of central and peripheral amyloid-\u03b2 clearance to treat Alzheimer\u2019s disease","volume":"120","author":"Zhang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0725","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0730","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41467-024-49028-z","article-title":"Co-aggregation with apolipoprotein E modulates the function of amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"15","author":"Xia","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb0735","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1021\/acsnano.5b03124","article-title":"GM1-modified lipoprotein-like nanoparticle: multifunctional nanoplatform for the combination therapy of Alzheimer\u2019s disease","volume":"9","author":"Huang","year":"2015","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb0740","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","article-title":"Cellular and pathological functions of tau","volume":"25","author":"Parra Bravo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0745","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1038\/srep09659","article-title":"Role of the tau n-terminal region in microtubule stabilization revealed by newendogenous truncated forms","volume":"5","author":"Derisbourg","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0750","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/brain\/awad024","article-title":"Tilavonemab in early Alzheimer\u2019s disease: results from a phase 2, randomized, double-blind study","volume":"146","author":"Florian","year":"2023","journal-title":"Brain"},{"issue":"29","key":"10.1016\/j.jconrel.2026.114946_bb0755","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1074\/jbc.AC119.009198","article-title":"Liquid\u2013liquid phase separation of tau protein: the crucial role of electrostatic interactions","volume":"294","author":"Boyko","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb0760","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.14283\/jpad.2024.163","article-title":"Phase 1 studies of the anti-tau monoclonal antibody JNJ-63733657 in healthy participants and participants with Alzheimer\u2019s disease","volume":"11","author":"Galpern","year":"2024","journal-title":"J. Prev Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0765","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ymthe.2022.01.009","article-title":"Inhibition of tau seeding by targeting tau nucleation core within neurons with a single domain antibody fragment","volume":"30","author":"Danis","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0770","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13024-024-00769-x","article-title":"Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies","volume":"19","author":"Song","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114946_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202307081","article-title":"Customized intranasal hydrogel delivering methylene blue ameliorates cognitive dysfunction against Alzheimer\u2019s disease","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater."},{"issue":"24","key":"10.1016\/j.jconrel.2026.114946_bb0780","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1073\/pnas.1504081112","article-title":"Tau stabilizes microtubules by binding at the interface between tubulin heterodimers","volume":"112","author":"Kadavath","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.jconrel.2026.114946_bb0785","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb0790","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1021\/acschemneuro.8b00182","article-title":"Structural basis of small molecule targetability of monomeric tau protein","volume":"9","author":"Kiss","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0795","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-5-45","article-title":"Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden","volume":"5","author":"O\u2019Leary","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0800","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41418-020-00667-x","article-title":"Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective","volume":"28","author":"Le Guerrou\u00e9","year":"2021","journal-title":"Cell Death Differ."},{"issue":"6639","key":"10.1016\/j.jconrel.2026.114946_bb0805","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.abn1366","article-title":"Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models","volume":"379","author":"Mukadam","year":"2023","journal-title":"Science"},{"issue":"754","key":"10.1016\/j.jconrel.2026.114946_bb0810","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj5958","article-title":"Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice","volume":"16","author":"Gaikwad","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0815","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-021-21443-6","article-title":"RING domains act as both substrate and enzyme in a catalytic arrangement to drive self-anchored ubiquitination","volume":"12","author":"Kiss","year":"2021","journal-title":"Nat. Commun."},{"issue":"6712","key":"10.1016\/j.jconrel.2026.114946_bb0820","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1126\/science.adp5186","article-title":"Aggregate-selective removal of pathological tau by clustering-activated degraders","volume":"385","author":"Benn","year":"2024","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb0825","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/med.22036","article-title":"The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution","volume":"44","author":"Kachanov","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104277","article-title":"Incisionless targeted adeno-associated viral vector delivery to the brain by focused ultrasound-mediated intranasal administration","volume":"84","author":"Ye","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2026.114946_bb0835","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12951-024-02963-x","article-title":"Tetrahedral framework nucleic acids inhibit A\u03b2-mediated ferroptosis and ameliorate cognitive and synaptic impairments in Alzheimer's disease","volume":"22","author":"Tan","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148663","article-title":"Intranasal delivery of insulin: An update on status quo and challenges for diabetes treatment","volume":"332","author":"Wong","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114946_bb0845","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb0850","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3233\/JPD-240272","article-title":"Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2024 update","volume":"14","author":"McFarthing","year":"2024","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0855","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41531-021-00196-5","article-title":"A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson\u2019s disease","volume":"7","author":"Pedersen","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0860","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ymthe.2017.11.015","article-title":"Selective \u03b1-Synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for Parkinson\u2019s disease","volume":"26","author":"Alarc\u00f3n-Ar\u00eds","year":"2018","journal-title":"Mol. Ther."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114946_bb0865","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114946_bb0870","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/15548627.2016.1179404","article-title":"A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition","volume":"12","author":"Song","year":"2016","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb0875","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/acsnano.9b06453","article-title":"A self-assembled \u03b1-Synuclein nanoscavenger for Parkinson\u2019s disease","volume":"14","author":"Liu","year":"2020","journal-title":"ACS Nano"},{"issue":"7886","key":"10.1016\/j.jconrel.2026.114946_bb0880","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114946_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence that substantia nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active","volume":"16","author":"Ni","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114946_bb0890","series-title":"Pharmaceutics","first-page":"1246","article-title":"Nose-to-brain delivery of antioxidants as a potential tool for the therapy of neurological diseases","author":"Bonferoni","year":"2020"},{"key":"10.1016\/j.jconrel.2026.114946_bb0895","first-page":"9812523","article-title":"Rational design of thermosensitive hydrogel to deliver nanocrystals with intranasal administration for brain targeting in parkinson\u2019s disease","volume":"19","author":"Tan","year":"2021","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.jconrel.2026.114946_bb0900","article-title":"Odoriferous therapy: a review identifying essential oils against pathogens of the respiratory tract","volume":"17","author":"Leigh-de Rapper","year":"2020","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.jconrel.2026.114946_bb0905","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jconrel.2020.02.033","article-title":"Nasal administration of nanoencapsulated geraniol\/ursodeoxycholic acid conjugate: towards a new approach for the management of parkinson\u2019s disease","volume":"321","author":"de Oliveira Junior","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102438","article-title":"Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson\u2019s disease","volume":"58","author":"Xu","year":"2024","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00355","article-title":"Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson's disease","volume":"21","author":"Eo","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb0920","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.7150\/thno.53474","article-title":"Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits","volume":"11","author":"Alexander","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0925","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1038\/s41598-021-90094-w","article-title":"Intranasal delivery of mitochondria for treatment of Parkinson\u2019s disease model rats lesioned with 6-hydroxydopamine","volume":"11","author":"Chang","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114946_bb0930","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.7150\/thno.84165","article-title":"Intranasal delivery of mitochondrial protein humanin rescues cell death and promotes mitochondrial function in Parkinson's disease","volume":"13","author":"Kim","year":"2023","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114946_bb0935","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJMe1215730","article-title":"Endovascular treatment for acute ischemic stroke--still unproven","volume":"368","author":"Chimowitz","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.jconrel.2026.114946_bb0940","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.jconrel.2026.114946_bb0945","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.0000000000003198","article-title":"Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry","volume":"87","author":"Mess\u00e9","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0950","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/brain\/awl325","article-title":"Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia","volume":"130","author":"Pignataro","year":"2007","journal-title":"Brain"},{"issue":"8022","key":"10.1016\/j.jconrel.2026.114946_bb0955","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41586-024-07684-7","article-title":"Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury","volume":"631","author":"Lai","year":"2024","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb0960","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1172\/JCI89354","article-title":"Astrocytic calcium release mediates peri-infarct depolarizations in a rodent stroke model","volume":"127","author":"Rakers","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.114946_bb0965","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"Stroke","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb0970","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41401-023-01061-2","article-title":"Angiogenesis after ischemic stroke","volume":"44","author":"Fang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0975","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/med.21817","article-title":"Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications","volume":"42","author":"Tuo","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb0980","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.14336\/AD.2021.1205","article-title":"Neuroprotective mechanisms of puerarin in central nervous system diseases: update","volume":"13","author":"Yu","year":"2022","journal-title":"Aging Dis."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb0985","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","article-title":"Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114946_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164934","article-title":"Nasal delivery of self-imaging ROS-responsive H\u2082S donors for enhanced neuroprotection in cerebral ischemia-reperfusion injury","volume":"519","author":"Zeng","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb0995","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/ijms25010178","article-title":"Circular RNAs: promising treatment targets and biomarkers of ischemic stroke","volume":"25","author":"Xu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114946_bb1000","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.120.045765","article-title":"Extracellular vesicle-mediated delivery of circular RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models","volume":"142","author":"Yang","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41467-023-36008-y","article-title":"FTO-dependent m6A modification of plpp3 in circSCMH1-regulated vascular repair and functional recovery following stroke","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114946_bb1010","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202500598","article-title":"Nose-to-brain delivery of circular RNA SCMH1-loaded lipid nanoparticles for ischemic stroke therapy","volume":"37","author":"Jia","year":"2025","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb1015","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","article-title":"Blood-brain barrier breakdown in acute and chronic cerebrovascular disease","volume":"42","author":"Yang","year":"2011","journal-title":"Stroke"},{"issue":"21","key":"10.1016\/j.jconrel.2026.114946_bb1020","doi-asserted-by":"crossref","first-page":"E1943","DOI":"10.1073\/pnas.1216203110","article-title":"Nogo-A is a negative regulator of CNS angiogenesis","volume":"110","author":"W\u00e4lchli","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb1025","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/STROKEAHA.107.507426","article-title":"Nogo-a expression after focal ischemic stroke in the adult rat","volume":"39","author":"Cheatwood","year":"2008","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1030","doi-asserted-by":"crossref","first-page":"20040","DOI":"10.1038\/s41598-019-56634-1","article-title":"Anti-Nogo-A antibodies prevent vascular leakage and act as pro-angiogenic factors following stroke","volume":"9","author":"Rust","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb1035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200057120","article-title":"Intranasal delivery of full-length anti-Nogo-A antibody: a potential alternative route for therapeutic antibodies to central nervous system targets","volume":"120","author":"Correa","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114946_bb1045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114946_bb1050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114946_bb1055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41419-023-06117-z","article-title":"Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma","volume":"14","author":"Bassot","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114946_bb1060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2020.09.028","article-title":"Different t-cell subsets in glioblastoma multiforme and targeted immunotherapy","volume":"496","author":"Wang","year":"2021","journal-title":"Cancer Lett."},{"issue":"6738","key":"10.1016\/j.jconrel.2026.114946_bb1065","article-title":"Distinct myeloid-derived suppressor cell populations in human glioblastoma","volume":"387","author":"Jackson","year":"2025","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb1070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.tips.2019.10.004","article-title":"A third shot at EGFR: new opportunities in cancer therapy","volume":"40","author":"Guardiola","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"13","key":"10.1016\/j.jconrel.2026.114946_bb1075","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.3390\/ijms23137207","article-title":"Glioblastoma treatment: state-of-the-art and future perspectives","volume":"23","author":"Rodr\u00edguez-Camacho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb1080","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","article-title":"FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme","volume":"14","author":"Cohen","year":"2009","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114946_bb1085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41582-018-0025-8","article-title":"Multidimensional communication in the microenvirons of glioblastoma","volume":"14","author":"Broekman","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114946_bb1090","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0b013e3182247068","article-title":"The paradoxical effect of bevacizumab in the therapy of malignant gliomas","volume":"77","author":"Chamberlain","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2026.114946_bb1095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2019.07.033","article-title":"Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles","volume":"309","author":"Sousa","year":"2019","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114946_bb1100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40263-017-0456-6","article-title":"EGFR as a target for glioblastoma treatment: an unfulfilled promise","volume":"31","author":"Westphal","year":"2017","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb1105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2015.09.002","article-title":"EGFR mutation promotes glioblastoma through epigenome and transcription factor network remodeling","volume":"60","author":"Liu","year":"2015","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb1110","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-18-1140","article-title":"Rindopepimut with bevacizumab for patients with relapsed EGFRvIII-expressing glioblastoma (ReACT): results of a double-blind randomized phase II trial","volume":"26","author":"Reardon","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.jconrel.2026.114946_bb1115","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2217\/nnm-2021-0169","article-title":"EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma","volume":"16","author":"de Cristo Soares Alves","year":"2021","journal-title":"Nanomedicine (London)"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114946_bb1120","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1021\/acsnano.1c07587","article-title":"A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic MicroRNA loading for intranasal delivery to mouse glioblastomas","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114946_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101911","article-title":"Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma","volume":"51","author":"Huang","year":"2023","journal-title":"Nano Today"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb1130","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/bjc.2011.169","article-title":"Targeting SDF-1\/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas","volume":"104","author":"Tseng","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb1135","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.7150\/thno.22736","article-title":"Targeting tumor hypoxia using nanoparticle-engineered CXCR4-overexpressing adipose-derived stem cells","volume":"8","author":"Jiang","year":"2018","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb1140","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114946_bb1145","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1158\/1078-0432.CCR-18-2402","article-title":"Glioblastoma-derived IL6 induces immunosuppressive peripheral myeloid cell PD-L1 and promotes tumor growth","volume":"25","author":"Lamano","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"47","key":"10.1016\/j.jconrel.2026.114946_bb1150","doi-asserted-by":"crossref","first-page":"23714","DOI":"10.1073\/pnas.1906346116","article-title":"Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1155","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41598-017-01279-1","article-title":"Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by galectin-1 intranasal knock-down strategy","volume":"7","author":"Van Woensel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114946_bb1160","doi-asserted-by":"crossref","first-page":"1016520","DOI":"10.3389\/fphar.2022.1016520","article-title":"Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb1165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/head.13476","article-title":"STOP 101: a phase 1, randomized, open-label, comparative bioavailability study of INP104, dihydroergotamine mesylate (DHE) administered intranasally by a I123 precision olfactory delivery (POD\u00ae) device, in healthy adult subjects","volume":"59","author":"Shrewsbury","year":"2019","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb1170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5214\/ans.0972.7531.12190210","article-title":"Serotonin and CGRP in migraine","volume":"19","author":"Aggarwal","year":"2012","journal-title":"Ann. Neurosci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114946_bb1175","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1526-4610.2005.05177.x","article-title":"Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial","volume":"45","author":"Goldstein","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.jconrel.2026.114946_bb1180","doi-asserted-by":"crossref","first-page":"3692065","DOI":"10.1155\/2022\/3692065","article-title":"Harnessing intranasal delivery systems of sumatriptan for the treatment of migraine","volume":"15","author":"Assadpour","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2026.114946_bb1185","first-page":"147","article-title":"Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine","volume":"11","author":"Tepper","year":"2018","journal-title":"Med. Devices (Auckl.)"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb1190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/head.13199","article-title":"AVP-825 (sumatriptan nasal powder) reduces nausea compared to sumatriptan tablets: results of the COMPASS randomized clinical trial","volume":"58","author":"Lipton","year":"2018","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114946_bb1195","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/head.12167","article-title":"Improved pharmacokinetics of sumatriptan with breath powered\u2122 nasal delivery of sumatriptan powder","volume":"53","author":"Obaidi","year":"2013","journal-title":"Headache"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114946_bb1200","article-title":"Reduced treatment-emergent nausea using AVP-825 vs. sumatriptan tablets: a comparative effectiveness study (p2.215)","volume":"86","author":"Shulman","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2026.114946_bb1205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107528","article-title":"Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans","volume":"211","author":"de Vries","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb1210","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/14737175.2024.2405741","article-title":"Intranasal zavegepant for the acute treatment of migraine","volume":"24","author":"Greco","year":"2024","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb1215","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond","volume":"103","author":"Russo","year":"2023","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114946_bb1220","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40265-023-01885-6","article-title":"Zavegepant: first approval","volume":"83","author":"Dhillon","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2026.114946_bb1225","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/pharmaceutics16070852","article-title":"Carrier systems for advanced drug delivery: improving drug solubility\/bioavailability and administration routes","volume":"16","author":"Losada-Barreiro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114946_bb1230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/ecp.12.69","article-title":"Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain","volume":"6","author":"Bulloch","year":"2013","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114946_bb1235","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.jconrel.2026.114946_bb1240","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.jconrel.2026.114946_bb1245","author":"European Medicines Agency"},{"key":"10.1016\/j.jconrel.2026.114946_bb1255","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.drudis.2021.06.011","article-title":"Brain safety concerns of nanomedicines: the need for a specific regulatory framework","volume":"26","author":"Szabat-Iriaka","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.114946_bb1260","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/cbe.4c00105","article-title":"Protein corona of nanoparticles: isolation and analysis","volume":"1","author":"Sun","year":"2024","journal-title":"Chem. Bio. Eng."},{"key":"10.1016\/j.jconrel.2026.114946_bb1265","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1021\/acsnano.8b03500","article-title":"Evolution of nanoparticle protein corona across the blood-brain barrier","volume":"12","author":"Cox","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114946_bb1270","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.jconrel.2026.114946_bb1275","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.7150\/thno.98473","article-title":"Intranasal delivery of imaging agents to the brain","volume":"14","author":"Almahmoud","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114946_bb1280","author":"European Medicines Agency"},{"key":"10.1016\/j.jconrel.2026.114946_bb1285","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-444-63855-7.00004-6","article-title":"Anatomy of the olfactory mucosa","volume":"vol. 164","author":"Salazar","year":"2019"},{"key":"10.1016\/j.jconrel.2026.114946_bb1290","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2023.06.005","article-title":"Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys","volume":"359","author":"Sasaki","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114946_bb1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105150","article-title":"Detailed comparison of anatomy and airflow dynamics in human and cynomolgus monkey nasal cavity","volume":"141","author":"Tian","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jconrel.2026.114946_bb1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.106949","article-title":"Analysis of spray pattern and plume geometry differences between generic and brand-name nasal sprays","volume":"108","author":"Morita","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114946_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125584","article-title":"The review of nasal drug delivery system: the strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption","volume":"676","author":"Wei","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114946_bb1310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40005-020-00482-z","article-title":"Factors influencing drug deposition in thenasal cavity upon delivery via nasal sprays","volume":"50","author":"Gao","year":"2020","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2026.114946_bb1315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123809","article-title":"Rivastigmine nasal spray for the treatment of Alzheimer\u2019s disease: olfactory deposition and brain delivery","volume":"652","author":"Guo","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114946_bb1320","doi-asserted-by":"crossref","first-page":"2400356","DOI":"10.1002\/mame.202400356","article-title":"In situ gels for nasal delivery: formulation, characterization and applications","volume":"310","author":"Qian","year":"2025","journal-title":"Macromol. Mater. Eng."},{"key":"10.1016\/j.jconrel.2026.114946_bb1325","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s13346-024-01721-8","article-title":"Rational development of fingolimod nano-embedded microparticles as nose-to-brain neuroprotective therapy for ischemic stroke","volume":"15","author":"Zhang","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.114946_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113826","article-title":"The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery","volume":"175","author":"Deruyver","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb1335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jare.2022.04.011","article-title":"Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device","volume":"44","author":"D\u2019Angelo","year":"2023","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/ph17010073","article-title":"Assessing nasal epithelial dynamics: impact of the natural nasal cycle on intranasal spray deposition","volume":"17","author":"Seifelnasr","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb1345","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.96.09020371","article-title":"A role for the nasal cycle in respiratory defence","volume":"9","author":"Eccles","year":"1996","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1350","doi-asserted-by":"crossref","first-page":"18466","DOI":"10.1038\/s41598-025-95148-x","article-title":"Nasal dominance potentiates intranasal oxytocin\u2019s anxiolytic effects","volume":"15","author":"Julius","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114946_bb1355","first-page":"97","article-title":"A tailored phytosomes based nose-to-brain drug delivery strategy: silver bullet for Alzheimer\u2019s disease","volume":"44","author":"Yue","year":"2025","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1360","doi-asserted-by":"crossref","first-page":"2411426","DOI":"10.1002\/adfm.202411426","article-title":"Lyotropic liquid crystalline based nasal spray for improved Parkinson\u2019s treatment: enhanced superior nasal tract deposition and antioxidation strategy","volume":"35","author":"Xia","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1365","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.apsb.2023.06.007","article-title":"Visualization of nasal powder distribution using biomimetic human nasal cavity model","volume":"14","author":"Su","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114946_bb1370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121858","article-title":"Anatomically realistic nasal replicas capturing the range of nasal spray drug delivery in adults","volume":"622","author":"Alfaifi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114946_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122118","article-title":"Validation and sensitivity analysis for a nasal spray deposition computational model","volume":"626","author":"Calmet","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb1380","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s13346-023-01488-4","article-title":"Optimized gravity-driven intranasal drop administration delivers significant doses to the ostiomeatal complex and maxillary sinus","volume":"14","author":"Seifelnasr","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.114946_bb1385","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.carbpol.2017.01.044","article-title":"Formulation of olfactory-targeted microparticles with tamarind seed polysaccharide to improve nose-to-brain transport of drugs","volume":"163","author":"Yarragudi","year":"2017","journal-title":"Carbohydr. Polym."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114946_bb1390","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.114946_bb1395","first-page":"S0167","article-title":"The FDA\u2019S plan to phase out animal testing, trends in biotechnology","volume":"21","author":"Gerke","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114946_bb1400","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/pharmaceutics15092245","article-title":"The path from nasal tissue to nasal mucosa on chip: part 1-establishing a nasal in vitro model for drug delivery testing based on a novel cell line","volume":"15","author":"Bendas","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114946_bb1405","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb1410","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114866","article-title":"Air-liquid interface cultures to model drug delivery through the mucociliary epithelial barrier","volume":"198","author":"Lee","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1415","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12974-023-02979-4","article-title":"Human-derived air\u2013liquid interface cultures decipher Alzheimer\u2019s disease\u2013SARS-CoV-2 crosstalk in the olfactory mucosa","volume":"20","author":"Shahbaz","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2026.114946_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131491","article-title":"Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine \u2013 development & characterization in physiologically relevant 3D tissue models","volume":"267","author":"Gadhave","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114946_bb1425","series-title":"2024 IEEE International Symposium on Olfaction and Electronic Nose (ISOEN)","first-page":"1","article-title":"Simulating olfactory system in vitro based on a transwell co-culture model","author":"Liu","year":"2024"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114946_bb1430","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7150\/thno.46750","article-title":"Expansion of murine and human olfactory epithelium\/mucosa colonies and generation of mature olfactory sensory neurons under chemically defined conditions","volume":"11","author":"Ren","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114946_bb1435","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/alz.12318","article-title":"A novel tau-based rhesus monkey model of Alzheimer\u2019s pathogenesis","volume":"17","author":"Beckman","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2026.114946_bb1440","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-animal-021419-083813","article-title":"Nonhuman primates in translational research","volume":"10","author":"Tarantal","year":"2022","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"10.1016\/j.jconrel.2026.114946_bb1445","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105029","article-title":"Species selection for nonclinical safety assessment of drug candidates: examples of current industry practice","volume":"126","author":"Namdari","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1450","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41418-020-0566-4","article-title":"Brain organoids: an ensemble of bioassays to investigate human neurodevelopment and disease","volume":"28","author":"Sidhaye","year":"2021","journal-title":"Cell Death Differ."},{"issue":"7652","key":"10.1016\/j.jconrel.2026.114946_bb1455","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature22047","article-title":"Cell diversity and network dynamics in photosensitive human brain organoids","volume":"545","author":"Quadrato","year":"2017","journal-title":"Nature"},{"issue":"6500","key":"10.1016\/j.jconrel.2026.114946_bb1460","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz5626","article-title":"Human CNS barrier-forming organoids with cerebrospinal fluid production","volume":"369","author":"Pellegrini","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114946_bb1465","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","article-title":"Precision drug delivery to the central nervous system using engineered nanoparticles","volume":"9","author":"Gao","year":"2024","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114946_bb1470","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-024-08487-6","article-title":"A framework for neural organoids, assembloids and transplantation studies","volume":"639","author":"Pa\u0219ca","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114946_bb1475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2025.06.017","article-title":"Forebrain assembloids support the development of fast-spiking human PVALB+ cortical interneurons and uncover schizophrenia-associated defects","volume":"113","author":"Walsh","year":"2025","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114946_bb1480","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41587-020-00763-w","article-title":"Generation of human striatal organoids and cortico-striatal assembloids from human pluripotent stem cells","volume":"38","author":"Miura","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114946_bb1485","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210083","article-title":"Engineering human brain assembloids by microfluidics","volume":"35","author":"Zhu","year":"2023","journal-title":"Adv. Mater."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114946_bb1490","article-title":"Modeling sporadic Alzheimer\u2019s disease in human brain organoids under serum exposure","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.114946_bb1495","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12951-025-03181-9","article-title":"Intranasal delivery of engineered extracellular vesicles promotes neurofunctional recovery in traumatic brain injury","volume":"23","author":"Li","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114946_bb1500","article-title":"Genetically engineered brain organoids recapitulate spatial and developmental states of glioblastoma progression","volume":"12","author":"Ishahak","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"37","key":"10.1016\/j.jconrel.2026.114946_bb1505","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk3700","article-title":"Modeling lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs","volume":"10","author":"Jin","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114946_bb1510","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41596-020-00433-w","article-title":"Generation and long-term culture of advanced cerebral organoids for studying later stages of neural development","volume":"16","author":"Giandomenico","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.114946_bb1515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s44385-025-00054-6","article-title":"From organoid culture to manufacturing: technologies for reproducible and scalable organoid production","volume":"3","author":"Kim","year":"2026","journal-title":"npj Biomed. Innov."},{"key":"10.1016\/j.jconrel.2026.114946_bb1520","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.tibtech.2024.11.021","article-title":"Vascularized human brain organoids: current possibilities and prospects","volume":"43","author":"Kistemaker","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114946_bb1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101323","article-title":"Brain organoids-on-chip for neural diseases modeling: history, challenges and trends","volume":"15","author":"Zhang","year":"2025","journal-title":"J. Pharm. Anal."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114946_bb1530","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","article-title":"A guide to machine learning for biologists","volume":"23","author":"Greener","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114946_bb1535","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/med.21764","article-title":"Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: state-of-the-arts and future directions","volume":"41","author":"Vatansever","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2026.114946_bb1540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123098","article-title":"Machine learning and sensitivity analysis for predicting nasal drug delivery for targeted deposition","volume":"642","author":"Calmet","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114946_bb1545","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.ymthe.2025.03.056","article-title":"Advances in AAV capsid engineering: integrating rational design, directed evolution and machine learning","volume":"33","author":"Nisanov","year":"2025","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114946_bb1550","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj3786","article-title":"Optimal trade-off control in machine learning-based library design, with application to adeno-associated virus (AAV) for gene therapy","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:20:11Z","timestamp":1783110011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":309,"alternative-id":["S0168365926003494"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114946","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision nose-to-brain therapeutics: Advances in drug delivery systems and emerging preclinical models","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114946"}}